Get the Stockscreener App
6.89
1.47%
0.10
After Hours:
7.04
0.15
+2.18%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc Stock (BHC) Latest News
Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart
Microkeratome Market Detailed In New Research Report 2025 | - openPR
Overt Hepatic Encephalopathy Treatment Market: Key - openPR
Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Analysts - Defense World
Cosmetic Surgery Market Forecast Report and Company - GlobeNewswire
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance
Actinic Keratosis Market Is Booming Worldwide 2025-2032 | - openPR
Bausch Health projects $4.95B-$5.1B revenue for 2025 with focus on growth and innovation - MSN
Scar Treatment Market Projected To Witness Massive Growth, - openPR
SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Bausch Health Companies Inc.(BHC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Bausch Health Companies Inc. (BHC): Among Top Stock Picks From Carl Icahn’s Portfolio - Insider Monkey
Bausch Health Companies: Stocks Overvalued by Analyst Consensus on TSX (BHC) - The Globe and Mail
Bausch Health Plans $5 Billion Debt Sale to Tackle Liabilities - Yahoo Finance
Blepharitis Market on Track for Major Expansion by 2034, - openPR
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R) - ACCESS Newswire
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R) - ACCESS Newswire
Is Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey
Coulter Partners Recruits Chief Medical Officer for Bausch Health - Hunt Scanlon Media
Acute Repetitive Seizures Market Booming with Advanced - openPR
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales - MSN
Bausch Health Companies (NYSE:BHC) Releases Quarterly Earnings Results, Misses Expectations By $0.44 EPS - MarketBeat
Van ECK Associates Corp Sells 119,848 Shares of Bausch Health Companies Inc. (NYSE:BHC) - Defense World
Bausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room (BLCO) - Seeking Alpha
Bausch Health Companies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Why Bausch Health Companies Inc. (BHC) Went Up On Thursday? - Yahoo Finance
Bausch Health Q4 Earnings Recap (Reiterating Buy Rating) (NYSE:BHC) - Seeking Alpha
‘New’ B+L? Wait Until Bausch Health Sells Stake - News & Insights
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday - Benzinga
Toronto Stocks Slip; Bausch Health Shares Climb on 4Q Beat, Rosy 2025 Outlook -February 20, 2025 at 12:24 pm EST - Marketscreener.com
Bausch Health Companies Inc. (NYSE:BHC) Q4 2024 Earnings Call Transcript - Insider Monkey
Bausch Health Companies Inc. SEC 10-K Report - TradingView
BAUSCH HEALTH COMPANIES INC. (NYSE:BHC) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc. - ACCESS Newswire
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises - MSN
Bausch: Q4 Earnings Snapshot - The Washington Post
Bausch Health Reports Strong 2024 Financial Performance - TipRanks
Bausch Health Companies Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics - Nasdaq
Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates - Nasdaq
Bausch Health Swings to Q4 Profit, Revenue Increases -- Shares Rise After Hours -February 19, 2025 at 05:27 pm EST - Marketscreener.com
Bausch Health Reports Strong 2024 Financial Results with Continued Growth - TipRanks
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance - Benzinga India
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results - Galveston County Daily News
Can Bausch Health's 7-Quarter Growth Streak Signal a Healthcare Sector Momentum Shift? - StockTitan
Bausch & Lomb aims to shake up contact lenses with deal off the table - Yahoo Finance UK
Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent - Yahoo Finance
Bausch Health Companies Q4 2024 Earnings Preview - MSN
Revenues Working Against Bausch Health Companies Inc.'s (NYSE:BHC) Share Price - Simply Wall St
0.77%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):